Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-16

Clinical Trial Update: Suzetrigine for Opioid-Free Recovery After Cesarean Delivery [Phase 4]

View source ↗

Summary

Suzetrigine is being studied in a Phase 4 trial for opioid-free recovery after cesarean delivery; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suzetrigine (Suzetrigine)

Snippet

Sponsor: University of Texas at Austin | Conditions: Cesarean Delivery, Cesarean Section | Phase 4 | Status: NOT_YET_RECRUITING